Squamous Cell Carcinoma of the Esophagus
- PMID: 36153105
- DOI: 10.1016/j.gtc.2022.06.005
Squamous Cell Carcinoma of the Esophagus
Abstract
Esophageal squamous cell carcinoma (ESCC) is common in the developing world with decreasing incidence in developed countries and carries significant morbidity and mortality. Major risk factors for ESCC development include significant use of alcohol and tobacco. Screening for ESCC can be recommended in high-risk populations living in highly endemic regions. The treatment of ESCC ranges from endoscopic resection therapy or surgery in localized disease to chemoradiotherapy in metastatic disease, and prognosis is directly related to the stage at diagnosis. New immunotherapies and molecular targeted therapies may improve the dismal survival outcomes in patients with metastatic ESCC.
Keywords: Endoscopic eradication therapy; Epidemiology; Esophageal squamous cell carcinoma; Neoadjuvant chemoradiotherapy; Prognosis.
Copyright © 2022 Elsevier Inc. All rights reserved.
Conflict of interest statement
Disclosure D C. Codipilly: None. K K. Wang: Research funding from PCI, Interscope, Erbe, Pentax Medical Consulting: Ironwood Pharma, GIE Medical
Similar articles
-
Outcomes of Radiation-Associated Esophageal Squamous Cell Carcinoma: The MSKCC Experience.J Gastrointest Surg. 2019 Jan;23(1):11-22. doi: 10.1007/s11605-018-3958-8. Epub 2018 Sep 13. J Gastrointest Surg. 2019. PMID: 30215197 Free PMC article.
-
Approach to Localized Squamous Cell Cancer of the Esophagus.Curr Treat Options Oncol. 2022 Oct;23(10):1370-1387. doi: 10.1007/s11864-022-01003-w. Epub 2022 Aug 31. Curr Treat Options Oncol. 2022. PMID: 36042147 Free PMC article. Review.
-
Update on Management of Squamous Cell Esophageal Cancer.Curr Oncol Rep. 2022 Mar;24(3):375-385. doi: 10.1007/s11912-021-01153-4. Epub 2022 Feb 10. Curr Oncol Rep. 2022. PMID: 35142974 Review.
-
Morbidity and Mortality of Patients Who Underwent Minimally Invasive Esophagectomy After Neoadjuvant Chemoradiotherapy vs Neoadjuvant Chemotherapy for Locally Advanced Esophageal Squamous Cell Carcinoma: A Randomized Clinical Trial.JAMA Surg. 2021 May 1;156(5):444-451. doi: 10.1001/jamasurg.2021.0133. JAMA Surg. 2021. PMID: 33729467 Free PMC article. Clinical Trial.
-
Impact of Interval Between Neoadjuvant Chemoradiation and Surgery Upon Morbidity and Survival of Patients with Squamous Cell Carcinoma of Thoracic Esophagus.Anticancer Res. 2018 Sep;38(9):5239-5245. doi: 10.21873/anticanres.12848. Anticancer Res. 2018. PMID: 30194173
Cited by
-
Association between tumor necrosis factor receptor 2 and progression and poor prognosis of tumor stage 2‑3 esophageal squamous cell carcinoma and stratified analysis.Oncol Lett. 2024 Aug 21;28(5):505. doi: 10.3892/ol.2024.14638. eCollection 2024 Nov. Oncol Lett. 2024. PMID: 39233825 Free PMC article.
-
Modulation of esophageal squamous cell carcinoma progression: the impact of CCR7 on JAK2/STAT3 signaling pathway.Discov Oncol. 2024 Sep 10;15(1):421. doi: 10.1007/s12672-024-01289-2. Discov Oncol. 2024. PMID: 39254762 Free PMC article.
-
Identification of a Prognostic Gene Signature Based on Lipid Metabolism-Related Genes in Esophageal Squamous Cell Carcinoma.Pharmgenomics Pers Med. 2023 Nov 4;16:959-972. doi: 10.2147/PGPM.S430786. eCollection 2023. Pharmgenomics Pers Med. 2023. PMID: 38023824 Free PMC article.
-
Innovative staining for endoscopic screening of early esophageal cancer and precancerous lesions: a preclinical study.Surg Endosc. 2025 Aug 28. doi: 10.1007/s00464-025-12108-2. Online ahead of print. Surg Endosc. 2025. PMID: 40877622
-
Unmasked immune reconstitution inflammatory syndrome towards B-cell non-Hodgkin lymphoma during treatment of esophageal actinomycosis in a patient with advanced HIV: a case report.AIDS Res Ther. 2023 Jul 14;20(1):48. doi: 10.1186/s12981-023-00526-y. AIDS Res Ther. 2023. PMID: 37452343 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical